Skip to Main Content

Paper Details

Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
J Immunother Cancer
2
2023
Author NameAffiliation
Bijal ShahMoffitt Cancer Center
John T SchillerDavid Geffen School of Medicine, University of California Los Angeles
Daniel J DeAngeloDana-Farber Cancer Institute
  • 1 - 3

Datasets

Release 1.2